DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Credit Suisse Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $267

Credit Suisse maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $278 to $267.

Benzinga · 03/06/2020 15:31

Credit Suisse maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $278 to $267.